PRESS RELEASE published on 03/14/2024 at 07:30, 2 years ago Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business Dermapharm Holding SE reaches upper end of adjusted EBITDA guidance range by achieving 10.8% revenue growth in 2023, proposes a dividend of EUR 0.88 per share for the year Financial Results Adjusted EBITDA Revenue Growth Dividend Proposal Dermapharm Holding SE
PRESS RELEASE published on 08/29/2023 at 07:30, 2 years 6 months ago Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall
PRESS RELEASE published on 08/16/2023 at 07:30, 2 years 7 months ago Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment
PRESS RELEASE published on 06/14/2023 at 17:00, 2 years 9 months ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share
PRESS RELEASE published on 06/13/2023 at 15:15, 2 years 9 months ago Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
PRESS RELEASE published on 05/15/2023 at 07:30, 2 years 10 months ago Dermapharm Holding SE: outstanding start to financial year 2023
PRESS RELEASE published on 03/28/2023 at 07:29, 2 years 11 months ago Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory
PRESS RELEASE published on 03/22/2023 at 11:00, 3 years ago EQS-Adhoc: Dermapharm Holding SE: 2022 dividend
PRESS RELEASE published on 03/14/2023 at 07:30, 3 years ago Dermapharm Holding SE: Dermapharm Holding SE's revenue exceeds one billion for the first time
PRESS RELEASE published on 01/05/2023 at 15:17, 3 years 2 months ago Dermapharm Holding SE intensifies its internationalisation efforts by acquiring Arkopharma
Published on 03/26/2026 at 23:00, 4 hours 8 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 5 hours 3 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 5 hours 8 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 5 hours 8 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 6 hours 8 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 6 hours 19 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 7 hours 47 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 7 hours 58 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 7 hours 58 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 8 hours 51 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 8 hours 51 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 9 hours 8 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 9 hours 8 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
